Antipsychotics, obesity, diabetes: Breaking the lock

Article

Second-generation antipsychotics (SGAs), while clinically better than their earlier counterparts, have been associated with dramatic weight gain, diabetes and an atherogenic lipid profile.

© 2023 MJH Life Sciences

All rights reserved.